<DOC>
	<DOC>NCT00025818</DOC>
	<brief_summary>A six-month clinical research trial to evaluate the effectiveness of an investigational medication for the treatment of dry eye syndrome in patients that have been diagnosed with moderate to severe dry eye syndrome, an autoimmune disorder AND/OR females 65 years of age or older.</brief_summary>
	<brief_title>Six Month Clinical Research Study for Patients With Moderate or Severe Dry Eye Syndrome</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Scleroderma, Systemic</mesh_term>
	<mesh_term>Scleroderma, Diffuse</mesh_term>
	<mesh_term>Sjogren's Syndrome</mesh_term>
	<mesh_term>Arthritis, Rheumatoid</mesh_term>
	<mesh_term>Keratoconjunctivitis</mesh_term>
	<mesh_term>Lupus Erythematosus, Systemic</mesh_term>
	<mesh_term>Keratoconjunctivitis Sicca</mesh_term>
	<mesh_term>Dry Eye Syndromes</mesh_term>
	<criteria>Eighteen years or older Diagnosis of moderate to severe dry eyes for at least 6 months and meet one or all of the following criteria: Diagnosis of autoimmune disorder Female 65 years of age or older</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2011</verification_date>
	<keyword>dry eyes</keyword>
	<keyword>rheumatoid arthritis</keyword>
	<keyword>Lupus</keyword>
	<keyword>Sjogren's syndrome</keyword>
	<keyword>myositis</keyword>
	<keyword>scleroderma</keyword>
	<keyword>autoimmune disorder</keyword>
</DOC>